CINECA IRIS Institutional Research Information System

DEAGLIO, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.546
EU - Europa 5.770
AS - Asia 2.821
AF - Africa 151
SA - Sud America 49
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.365
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.436
IT - Italia 1.839
CN - Cina 1.616
IE - Irlanda 724
SE - Svezia 595
DE - Germania 515
UA - Ucraina 497
KR - Corea 419
FR - Francia 392
FI - Finlandia 306
SG - Singapore 289
AT - Austria 266
GB - Regno Unito 201
VN - Vietnam 161
PL - Polonia 136
SN - Senegal 118
CA - Canada 102
IN - India 78
JP - Giappone 75
BE - Belgio 60
ES - Italia 46
HK - Hong Kong 44
NL - Olanda 36
CZ - Repubblica Ceca 28
CH - Svizzera 27
IR - Iran 27
TW - Taiwan 22
BY - Bielorussia 21
UZ - Uzbekistan 21
AU - Australia 19
BR - Brasile 19
PH - Filippine 18
EG - Egitto 14
RU - Federazione Russa 14
RO - Romania 13
GR - Grecia 12
CL - Cile 11
DK - Danimarca 10
MO - Macao, regione amministrativa speciale della Cina 10
NG - Nigeria 9
NO - Norvegia 8
TR - Turchia 8
CO - Colombia 7
LU - Lussemburgo 7
TH - Thailandia 7
AR - Argentina 6
ID - Indonesia 6
MX - Messico 6
PK - Pakistan 6
SA - Arabia Saudita 6
NZ - Nuova Zelanda 5
EU - Europa 4
HU - Ungheria 4
ZA - Sudafrica 4
EC - Ecuador 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
HR - Croazia 2
MA - Marocco 2
MY - Malesia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
EE - Estonia 1
GH - Ghana 1
GT - Guatemala 1
IL - Israele 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SI - Slovenia 1
Totale 16.365
Salva come PNG Salva come JPEG
Città #
Chandler 1.206
Beijing 924
Dublin 722
Torino 608
Houston 435
Ashburn 401
Fairfield 399
Ann Arbor 312
Jacksonville 287
Vienna 259
Nyköping 250
Wilmington 247
Villeurbanne 244
Medford 238
Princeton 236
Woodbridge 192
Dearborn 185
Turin 177
Singapore 164
Cambridge 159
Seattle 136
Dong Ket 131
Milan 125
Warsaw 121
Redwood City 103
Boston 97
Fremont 86
Shanghai 79
New York 77
Guangzhou 67
Pisa 67
Nanjing 60
Boardman 52
Centro 52
San Mateo 51
Hangzhou 49
Norwalk 44
Brussels 43
Toronto 38
San Diego 37
Novara 34
Hefei 33
Rome 28
Falls Church 27
Kunming 26
Düsseldorf 23
Jinan 22
Xian 22
Ottawa 19
Verona 19
Bologna 18
Mountain View 18
Tokyo 18
Wuhan 18
Lappeenranta 17
Washington 17
Los Angeles 16
Nanchang 16
Scilla 16
Seoul 16
Garessio 15
Chengdu 14
Hong Kong 14
Philadelphia 14
Shenyang 14
Taipei 14
Upper Marlboro 14
Barcelona 13
Detroit 13
Hebei 13
Perugia 13
Fuzhou 12
Lachine 12
London 12
Munich 12
Paris 12
Belfast 11
Brookline 11
Helsinki 10
Naples 10
Pune 10
Zhengzhou 10
Central District 9
Changsha 9
Chennai 9
Florence 9
Phoenix 9
Redmond 9
San Francisco 9
Silver Spring 9
Vestignè 9
Abuja 8
Columbus 8
Marche 8
Nürnberg 8
Piemonte 8
Salvador 8
Tianjin 8
Amsterdam 7
Berlin 7
Totale 10.007
Salva come PNG Salva come JPEG
Nome #
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 681
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. 459
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 389
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 291
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 290
Mir-214 and mir-148b targeting inhibits dissemination of melanoma and breast cancer 258
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 223
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 216
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 191
Usage of IGHV4-39 with Stereotypic B Cell Receptor Is An Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome 189
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia. 173
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 173
Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of patent WO2013063498. 165
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 162
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 157
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 155
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 144
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 140
Targeting metabolism and survival in chronic lymphocytic leukemia and richter syndrome cells by a novel NF-κB inhibitor 136
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 134
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. 125
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 125
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation 124
Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. 123
The genetics of nodal marginal zone lymphoma 123
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 115
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 115
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 114
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 113
The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies 108
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA 107
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells 107
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 106
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 105
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 105
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 103
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. 100
Immune response dysfunction in chronic lymphocytic leukemia: Dissecting molecular mechanisms and microenvironmental conditions 99
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 98
ASSOCIATION BETWEEN RS12917707 SINGLE NUCLEOTIDE POLYMORPHISM AT THE UMOD PROMOTER REGION AND SERUM UROMODULIN LEVELS: IMPLICATIONS IN KIDNEY TRANSPLANTATION 96
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 95
Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines 93
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 92
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 91
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death 90
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential 89
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 89
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 88
Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia 88
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 87
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression 86
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 85
Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia. 85
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 84
CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? 84
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology 82
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 82
All-trans retinoic acid inhibits the growth of breast cancer cells by up-regulating ICAM-1 expression. 81
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells 80
CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA 80
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 80
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity 80
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 79
CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines. 78
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 78
The PD-1/PD-L1 Axis Contributes to T Cell Dysfunction in Chronic Lymphocytic Leukemia 77
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. 77
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 77
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient–derived xenograft mouse models 77
CD38 at the junction between prognostic marker and therapeutic target 76
A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. 76
HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity 75
CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus 74
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 74
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle. 74
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 73
Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists 73
Cationization of monoclonal antibodies: another step towards the 'magic bullet'? 72
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle. 72
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival 71
Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. 71
Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway. 71
Rapid and sensitive detection of recombinant soluble proteins in the supernatant of transfected mammalian cells. 70
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells 70
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. 70
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 70
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 70
CD38 in chronic lymphocytic leukemia: from bench to bedside? 69
Genome-Wide Study Updates in the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN) 69
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia 68
Signaling and activation, calcium anc cytokine release, receptorial activities of the human CD38 family NAD+-converting enzymes 68
Structural, functional and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum 68
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 68
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 68
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. 68
CD38 Workshop Report 67
E2A is a transcriptional regulator of CD38 expression in chroniclymphocytic leukemia 67
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer 67
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 66
HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. 66
Totale 11.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.710
article - articoli 0
book - libri 0
conference - conferenze 8.444
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.154
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.180 59 73 114 259 144 359 268 171 213 249 179 92
2020/20212.532 172 195 151 107 281 145 271 173 354 236 164 283
2021/20222.668 126 111 139 192 156 162 176 121 106 250 606 523
2022/20233.613 399 343 78 387 280 870 267 207 401 110 168 103
2023/20241.848 224 309 113 70 147 224 71 153 30 107 143 257
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 16.965